The Carlyle Group Inc. Common Stock
CGThe Carlyle Group Inc. (CG) is a global investment firm specializing in private equity, real estate, credit, and infrastructure investments. Founded in 1987, it offers financial advisory and asset management services to a diverse range of clients, including institutions and high-net-worth individuals. The firm is known for its extensive investment portfolio across various industries and geographies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 19, 2025 | $0.35 | 2025-11-10 | 2025-11-10 |
| August 28, 2025 | $0.35 | 2025-08-18 | 2025-08-18 |
| May 27, 2025 | $0.35 | 2025-05-19 | 2025-05-19 |
| February 28, 2025 | $0.35 | 2025-02-21 | 2025-02-21 |
| November 25, 2024 | $0.35 | 2024-11-18 | 2024-11-18 |
Dividends Summary
- The Carlyle Group Inc. Common Stock has issued 43 dividend payments over the past 22 years
- The most recent dividend was paid 19 days ago, on November 19, 2025
- The highest dividend payed out to investors during this period was $0.46 per share
- The average dividend paid during this period was $0.37 per share.
Company News
Microsoft's stock experienced volatility after a report about lowered AI sales quotas, which the company denied. The incident highlighted ongoing competitive challenges in the AI market, particularly with Alphabet's recent Gemini model release.
The US Treasury Department authorized potential buyers to negotiate Lukoil's foreign asset sales through December 13, following sanctions imposed last month on Russia's largest oil companies in response to their role in financing the Ukraine war.
Global investment firm Carlyle announced pricing of $800 million senior notes due in 2035, with the offering expected to close on September 19, 2025, and proceeds to be used for general corporate purposes.
Blue Owl Capital is set to report its second-quarter 2024 results on Aug 7. The company's earnings and revenue are expected to decline year-over-year, and the Zacks Rank #3 (Hold) stock has underperformed its peers and the broader market year-to-date.
Entities associated with the Carlyle Group have sold over $4.8 million worth of shares in QuidelOrtho Corp, a company specializing in diagnostic substances. The sales were conducted in accordance with a Rule 10b5-1 trading plan, and the entities still hold a significant number of shares in the company.
